Press Release – New York, NY – May 16, 2023 – Sichenzia Ross Ference LLP announced today that it represented Sunshine BioPharma, Inc. (Nasdaq: SBFM) (the “Company”), a pharmaceutical company offering …
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering
Press Release – New York, NY – May 11, 2023 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp., (NASDAQ: “LEXX”), a global innovator in drug delivery platforms, …
Sichenzia Ross Ference LLP Represents Spartan Capital Securities, LLC in $6.25 Million Registered Direct Offering of Common Stock of Processa Pharmaceuticals, Inc.
Press Release – New York, New York – February 15, 2023 - Sichenzia Ross Ference LLP announced today that it represented Spartan Capital Securities, LLC in a registered direct offering of common stock …
Sichenzia Ross Ference LLP Represents Verb Technology Company, Inc. in $7.2 Million Underwritten Public Offering of Common Stock
Press Release – New York, NY – January 26, 2023 – Sichenzia Ross Ference LLP announced today that it represented Verb Technology Company, Inc. (NASDAQ: VERB), the leader in interactive …
Sichenzia Ross Ference LLP Represents Murphy Canyon Acquisition Corp. in Definitive Merger Agreement with Conduit Pharmaceuticals Limited
Press Release – New York, NY November 9, 2022 – Sichenzia Ross Ference LLP announced today that it represented Murphy Canyon Acquisition Corp. (Nasdaq: MURF), a publicly traded special purpose …
